Abstract

Current status of the nasopharyngeal angiofibroma treatment. Rev Med Hered [online]. 2018, vol.29, n.1, pp.52-57. ISSN 1018-130X.  http://dx.doi.org/https://doi.org/10.20453/rmh.v29i1.3262.

The nasopharyngeal angiofibroma is an infrequent benign tumor that presents in male patients, predominantly preadolescents, highly vascularized which explains the high volume nasal bleeding during the course of the disease, that can even cause fatal outcomes during surgery. The anatomic location where this tumor originates and the following compromise of adyacent structures in the skull base explains the complexity of the treatment of this tumor. The following article review the state of the art of the treatment offered to the patients published in the literature. The election treatment is surgery, with a growing tendency to offer minimally invasive techniques, and recommending other modalities, such as radiotherapy, for advanced tumors not amenable to surgical resection.

Keywords : Neoplasms; vascular tissue; therapeutics; angiofibroma.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )